Literature DB >> 26188043

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

Chang Han, Tong Wu.   

Abstract

Entities:  

Year:  2015        PMID： 26188043      PMCID： PMC4505029          DOI： 10.1074/jbc.A115.500562

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  3 in total

1.  PGE2 /EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy.

Authors:  Siwei Tan; Xiaoliang Chen; Minyi Xu; Xiaoli Huang; Huiling Liu; Jie Jiang; Yu Lu; Xiaojie Peng; Bin Wu
Journal:  Br J Pharmacol       Date:  2017-03-25       Impact factor: 8.739

2.  Probing the Anti-Cancer Potency of Sulfated Galactans on Cholangiocarcinoma Cells Using Synchrotron FTIR Microspectroscopy, Molecular Docking, and In Vitro Studies.

Authors:  Boonyakorn Boonsri; Kiattawee Choowongkomon; Buabarn Kuaprasert; Thanvarin Thitiphatphuvanon; Kittiya Supradit; Apinya Sayinta; Jinchutha Duangdara; Tawut Rudtanatip; Kanokpan Wongprasert
Journal:  Mar Drugs       Date:  2021-04-30       Impact factor: 5.118

3.  The ω-3 polyunsaturated fatty acids prevented colitis-associated carcinogenesis through blocking dissociation of β-catenin complex, inhibiting COX-2 through repressing NF-κB, and inducing 15-prostaglandin dehydrogenase.

Authors:  Young-Min Han; Migyeung Jeong; Jong-Min Park; Mi-Young Kim; Eun-Jin Go; Ji Young Cha; Kyung Jo Kim; Ki Baik Hahm
Journal:  Oncotarget       Date:  2016-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.